Stability testing of Pharmaceuticals
| Type | Course |
|---|---|
| Language | English |
| Date |
February 19, 2007
to February 21, 2007 |
| Venue |
The Moller Centre Cambridge, CB3 0DE GB |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
Susan Hughes RPSGB 1 lambeth High Street London, SE1 7JN GB 020 7572 2640 020 7572 2506 science@rpsgb.org |
| Add event to calendar |
|
An intensive course on the stability testing of pharmaceuticals. Criteria for product stability, problems with specific product types, new technology for stability assessment, and applications and limitations of stability test procedures. UK and international regulatory aspects, and ICH guidelines for stability testing within the EU, Japan and the USA. The course is designed to be applicable to those currently working on all aspects of stability testing, including those new to the area.
Speakers
Katrine Bonner Colorcon Limited
Dr Graham Leonard GlaxoSmithKline
Dr Paul Royall University of East Anglia
Dr Andrew Lipczynski Pfizer Research
Dr Steve Flatman Lonza Biologics
Mr Gerry Maxwell NDA Analytics
Dr John Beaman Pfizer
Dr Andy Rignall AstraZeneca
Ms Sue Harris MHRA
Session titles
Chemical and physical aspects of drug substance and drug product stability
Development pharmaceutics and stability testing
Rational design of stability testing methods
Selection and validation of stability-indicating analytical methods
Stability testing of biotechnology products
Product packaging and stability testing
Stability testing - the UK and European regulatory perspective
International aspects of stability testing for product registration
Characterising materials with respect to physical stability
Practical aspects of finished product testing
